Does RAVULIZUMAB-CWVZ Cause Sars-cov-2 test positive? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Sars-cov-2 test positive have been filed in association with RAVULIZUMAB-CWVZ. This represents 0.3% of all adverse event reports for RAVULIZUMAB-CWVZ.
33
Reports of Sars-cov-2 test positive with RAVULIZUMAB-CWVZ
0.3%
of all RAVULIZUMAB-CWVZ reports
1
Deaths
10
Hospitalizations
How Dangerous Is Sars-cov-2 test positive From RAVULIZUMAB-CWVZ?
Of the 33 reports, 1 (3.0%) resulted in death, 10 (30.3%) required hospitalization.
Is Sars-cov-2 test positive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Sars-cov-2 test positive?
OCRELIZUMAB (1,421)
ADALIMUMAB (1,301)
DUPILUMAB (860)
NIRMATRELVIR\RITONAVIR (538)
LENALIDOMIDE (469)
SECUKINUMAB (378)
CERTOLIZUMAB PEGOL (361)
RISANKIZUMAB-RZAA (335)
RITUXIMAB (305)
UPADACITINIB (281)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Sars-cov-2 test positive Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST